Four Brands, One Mold: When Supplier Exclusivity Breaks Down on the Beauty Shelf

FOUR BRANDS, ONE MOLD: WHEN SUPPLIER EXCLUSIVITY BREAKS DOWN ON THE BEAUTY SHELF

OPENING: The moment four identical products appeared at once

One morning in late September, social media users across North America and Asia opened their phones and saw the same thing appear in four different places: a lemon-slice-shaped hydrogel eye patch, packed in a clear plastic case, with a design seemingly cast from a single blueprint. Wonder Bath released its "Slice Serum" line first. Then Fenty Skin by Rihanna, Huda Beauty by Huda Kattan, and Glow Recipe by co-founders Sarah Lee and Christine Chang each launched a product whose design sat close enough together for consumers to photograph and compare side by side. None of the four brands called it copying. But the online community did. Within a matter of weeks, the question "who copied whom" became the central topic, and someone on the inside spoke up: Huda Kattan said the brands "were lied to on the exclusivity with the packaging supplier."

This is where I want to pause before continuing. When a rumor starts spreading and people only care about the highlight — here, the clear plastic cases, the lemon-slice shape, the pastel pink tones — what gets ignored is the contract. People watch highlights, I watch contracts. Both contain a turnaround. And in this story, the turnaround lies in the fact that four brands did not copy each other in the ordinary sense; they walked through the same narrow door, held by a single person with the key.

CONTEXT: The hydrogel patch market — where difference is harder to sell than sameness

To understand why a story about eye patches could blow up into an exclusivity scandal, it needs to be placed in the right industry context. The hydrogel patch is not a new product. It took root in Korean beauty nearly a decade ago, grew up in K-beauty stores in Seoul, then spread to China and Southeast Asia, and later entered the North American market through indie labels. The structural characteristic of this product line was defined from the start by an "open formula": the key actives are mainly fruit juices, niacinamide, hyaluronic acid, caffeine, and peptide chains. Ingredients are easy to source, the gel-casting process is easy to replicate, and packaging — the part consumers see first — depends on a small group of molding workshops.

In other words, this is an industry where the production structure itself pushes brands toward sameness, whether they want it or not. In such an industry, the only thing that creates difference is two factors: the specific chemical formula, and exclusive access to packaging or molds.

When both factors fall under suspicion, the entire competitive order shakes.

According to the timelines I gathered, Wonder Bath is the name that appears earliest, with its "Slice Serum" line tied to a mid-summer date, arriving roughly two months before the Western brands' teaser phase. Fenty Skin then announced a product with teaser imagery before September 17. Huda Beauty and Glow Recipe followed closely behind. These four are not companions; Fenty is a major name tied to Rihanna, Huda Beauty is tied to a cosmetics empire with tens of millions of followers, Glow Recipe defines itself through "clean" formulas inspired by Korea, and Wonder Bath is smaller but holds the first-mover advantage.

One thing must be stated plainly: the retail price of this product sits at roughly twenty-nine US dollars for about sixty pieces. This is the only financial data point citable in the entire story. It is not a transfer fee, not a signing bonus, not a release clause. It is a retail price. But this number is precisely what reveals what is being contested beneath the surface: a low-margin, high-volume product dependent on packaging costs and supplier capacity. In the consumer-goods economy, that is where the real game is played.

CORE ANALYSIS: The exclusivity clause and the first-mover trap

This is the section requiring the highest precision, because any loose interpretation from the previous section will be broken here.

When Huda Kattan says the brands "were lied to on the exclusivity with the packaging supplier," she is describing a specific contractual structure: an agreement in which a supplier commits not to provide the same packaging design or the same mold to competing brands for a certain period and market scope. This clause is common in consumer goods, not rare. It exists for a clear reason: if brand A pays to develop a distinct packaging design, it does not want to see brand B on the shelf with that exact design within a few months.

But there are three layers to the problem here that mass media merged into one.

The first layer is pure observation. What do we observe? We observe four products with visually similar designs reaching the market within a short period. That is design similarity. This is a verifiable fact via photographs.

The second layer is inference. What do we infer? We can infer that four brands did not independently dream up the same design, unless they all used a common manufacturing source or a common inspiration. This is inference, not observation.

The third layer is allegation. Huda Kattan alleges that an exclusivity promise was broken. This is an allegation from a single source, and according to reports, the supplier is not named, no second party has confirmed it, and no legal action has been announced.

These three layers must be separated. The problem is that the media did not separate them.

Now, look inside the structure Kattan is describing. If a single packaging supplier truly sits behind multiple brands, that model reflects a familiar paradox in consumer-goods manufacturing: the more brands want to be different, the more they must rely on the same small number of suppliers with sufficient technical capability. When that capability is limited to a small group — sometimes only two or three workshops able to cast quality eye-patch gel at scale — bargaining power lies with the supplier, not the brand.

In that context, two scenarios are possible.

The first scenario: the supplier sells the same design to multiple parties, but the parties understand the exclusivity scope differently. One thinks it bought North American exclusivity, one thinks it bought global exclusivity, one thinks it only bought manufacturing priority. These misunderstandings are extremely common in complex industrial contracts, especially when the contract is drafted in loose language without a detailed annex on design scope.

The second scenario: the supplier deliberately broadens production for multiple parties, exploiting the fact that exclusivity clauses are hard to enforce across borders. If brand A buys exclusivity in one jurisdiction, the supplier can still sell to brand B in another, and brand B can still export back into A's market via cross-border e-commerce channels. This is a loophole that traditional exclusivity clauses were not designed to seal.

Both scenarios lead to the same result on the shelf: four identical products, a moral story, and no one in court.

CONTRARIAN BLIND SPOT: The turnaround lies in the fact that the alleged copier is the first mover

This is where the media narrative collapses under the weight of hidden data.

According to the launch sequence I recorded, Wonder Bath is the name with the earliest product launch. It is a much smaller brand than Fenty Skin, Huda Beauty, or Glow Recipe. In the logic of the "who copied whom" story, people assume the big brand is the creator and the small brand is the imitator. But when timeline data is placed on the table, the order reverses: the small brand moved first, the large brands followed.

This does not automatically make the large brands copiers. It only means the story "the big guys swallowed the little guy's idea" — the story the online community most likes to tell — does not match the timeline.

And there is another possibility few want to consider: none of the four brands copied anyone, because all four were reacting to the same market signal sent by a third party. That signal could come from a rising packaging trend, from an industry trade fair, from a supplier pitching a new mold design to all of its clients at once.

If that is the case, the word "copy" is a misnomer. The reality is structural convergence: when multiple parties face pressure to launch products quickly, share the same supply network, and read the same trend signal, their products will look alike — not because of plagiarism, but because of convergence.

This is where the contrarian angle matters. People like stories with a villain. Villains are easy to tell, easy to share, easy to generate engagement. But the correct story often has no villain, only a system that makes everyone behave the same way.

There is a deeper layer that Kattan's allegation inadvertently touches. When she says the brands "were lied to," she is not only accusing the supplier. She is admitting something unfavorable to the industry itself: what brands call "exclusivity" turned out to be a verbal agreement, a vague clause, or an expectation never written down tightly enough. If the exclusivity clause truly existed and was truly breached, there would be grounds for a commercial claim — and according to information I have, no legal action has been announced. That is the most noteworthy detail in the entire story, and it is barely mentioned in the reports.

One more thing must be stated clearly: the supplier is not named in the available information. No name, no chain of accountability, no one responsible. This is not accidental. When a story has a villain without a name, that story is designed never to close.

STRATEGIC ANALYSIS: Two opposing communication strategies in the same event

What is interesting here is that the four brands did not react the same way, even though they were in the same situation.

Huda Kattan chose confrontation. She spoke with the voice of the aggrieved, saying everyone "got screwed over." This is an image-building strategy: turning the brand into a victim of an unfair system, turning consumers into allies in the effort to expose the truth. The risk of this strategy is that if the allegation is not proven, the brand loses credibility for betting on an unverified story.

Glow Recipe chose another path. Co-founders Sarah Lee and Christine Chang emphasized formula differentiation and effort, with a message along the lines of having "worked tirelessly." This is a de-escalation strategy: shifting the story from "who copied whom" to "look at our formula." The risk is that consumers may not be able to distinguish formulas if the packaging is identical on the shelf.

These two strategies reflect two different levels of risk tolerance. Kattan is willing to confront to gain a communication edge. Lee and Chang chose to protect core value through product differentiation.

Notably, both strategies work well in the short term, and both fail to solve the root problem. The root problem is: if consumers standing before the shelf cannot distinguish whose product is whose, the brand is gradually losing pricing power. The twenty-nine-dollar price for sixty pieces only holds if buyers believe they are buying something different. When that belief wavers, the game becomes a price war, and a price war on a low-margin product is a war only the supplier wins.

There is an alarming sign for the brands: all four "responded playfully online" in a way the media described as turning the incident into a "viral beauty conversation." Playfulness is a reasonable crisis-management tactic. But excessive playfulness can be read as admitting the matter is not serious. If it is not serious, why be playful? If it truly is serious, why joke?

There is no clean answer to that question. And it is precisely this ambiguity that keeps the story alive longer than it deserves.

STRUCTURAL COMPARISON WITH THE FOOTBALL TRANSFER MARKET

I work at reading transfer contracts, and I cannot help viewing this story through that lens. There are three structural similarities worth analyzing — not to force a fit, but to show that certain power models repeat across industries.

The first similarity lies in the exclusivity structure. In football, kit and equipment sponsorship contracts often contain very tight exclusivity clauses: a sports brand signs with a club and excludes rivals from that club's commercial space. These clauses are sometimes breached and sometimes lead to real litigation. But the key difference is that in football, exclusivity clauses are drafted by professional legal teams, with scope annexes, penalty clauses, and dispute-resolution mechanisms. In the eye-patch story, the brands may have signed much vaguer agreements, and that is precisely the root of the trouble.

The second similarity lies in the rumor cycle. People watch highlights, I watch contracts. Both contain a turnaround. In the transfer market, a rumor flares up, spreads, then gets broken by a fact nobody noticed — a release clause, a deferred payment, a sell-on clause. Here, the story "four brands copied each other" flared up, spread, and should have been broken by one simple fact: the chronology and the existence of a shared supplier. But it was not broken, because no one was willing to publish that information. Leaks are never accidents. Someone always wants you to read page three.

The third similarity, and the most important one, lies in concentrated risk structure. In football, when a club depends on a single sponsor or a single kit supplier, the club loses bargaining power. The same holds in consumer goods: when multiple brands depend on a single packaging supplier, bargaining power belongs to the supplier. The trap is not in copying. The trap is in allowing dependence.

One thing must be said plainly: this is a structural comparison, not a football event. The original story contains no club, player, coach, or competition. But it contains a power model that anyone working in the transfer market recognizes immediately: when control of a chokepoint in the supply chain concentrates in one hand, everything downstream of that chokepoint can be manipulated.

QUANTIFYING THE RUMOR: Turning whispers into numbers

The price on the board is a number. The price behind the curtain is the story. In that spirit, let us try to quantify this story with verifiable figures.

The first number: four. Four brands, four launches, within a short window. This is a number verifiable through photographs and launch calendars.

The second number: twenty-nine US dollars for about sixty pieces. This is the retail price, and it shows a low-price, high-volume product dependent on packaging and logistics costs.

The third number: about two months. This is the gap between when Wonder Bath is said to have launched its "Slice Serum" line and the Western brands' teaser phase. A two-month gap is not enough to develop a new mold from scratch, but it is enough to receive goods from an existing mold.

The fourth number: one. This is the number of packaging suppliers said to stand behind multiple brands. No name, no confirmation, but this is the central number of the entire story.

The fourth number is the unverifiable number, and precisely because of that it decides everything. When the central figure of a story has no name, that story cannot close on any conclusion. It can only keep spreading.

When I write about a transfer deal, I always use three layers of verification: club sources, agent sources, and contract data. Here, the third layer — contract data — is entirely absent. No contract has been published. No clause has been quoted. No supplier name has been given. There is only a statement from one side.

A statement from one side, even from a credible person, is still only a statement. In my work, that is the kind of information I rate eight out of ten for source credibility, but not enough to reach a final conclusion.

INTELLIGENCE FROM THE SYSTEM'S EDGE: What does not appear on television

In every supply-chain story, the people who know the most are usually not the spokespeople on television. The World Cup dressing room does not only contain studs; it also contains a hotline. In this story, the figures holding the most important information do not appear in any report.

They are workshop managers. They are brand operations staff handling orders with the supplier. They are warehouse workers who see the same shipment going to different addresses. These are the people who know exactly who ordered first, who ordered later, who was promised what, and who truly holds exclusivity.

No report cites these people. That is a major omission. In my work, when intelligence from the system's edge goes silent, I treat it as a sign that the story has not been fully investigated.

There is one small but notable detail in the timelines I have: one launch date is tied to mid-summer, while other events are tied to September. This discrepancy may just be a record-keeping issue, but it may also signal a lengthy product-development phase before the brands announced. If there was a long development phase, the "copied within weeks" story becomes even harder to sustain.

Players run fast on the pitch, but they run slower than my information. In this case, information ran faster than data, and data ran faster than truth. That is a problem.

RISK ANALYSIS AND INDICATORS TO WATCH

As a market observer rather than a participant, I view this story through three risk indicators.

The first indicator is differentiation risk. Four products that look alike on the shelf is a bad signal. Consumers buy with their eyes before they buy with their minds. If the eyes cannot tell them apart, the mind will use the cheapest criterion — price. In consumer goods, when buyers shift to price comparison, margins shrink, and the game shifts from creation to production. The winner in that game is not the brand. The winner is the supplier.

The second indicator is supplier-dependency risk. If one supplier serves multiple competing brands, that supplier controls a strategic chokepoint. This is the kind of risk football has learned about many times: when you depend on a chokepoint, you no longer decide your own speed and direction.

The third indicator is media risk. This story is in the acceleration phase of an attention cycle. It has enough facts to survive in the short term and may fade quickly within a month. But its legacy may last longer: consumers may remember that these four brands have similar products, and that memory could harm brand value over the long term.

These are the signals to watch in the coming weeks. First, whether the packaging supplier is named. If named, the story may move from media to legal. Second, whether an independent party tests the formulas and confirms the actives are truly different. If the formulas are truly distinct, the "copy" story collapses. If the formulas are identical, the brands lose value. Third, whether any legal action is announced. Silence on the legal front is a strong sign that the exclusivity clause was not tight enough to sue over.

CONCLUSION: The lesson is not about copying, but about contracts

In 2026, a new sports platform invited me on air and I published a number about a transfer deal that the entire livestream laughed at. Three days later, that number became reality and I received more than two thousand apologies. The lesson I kept from that was not "I was right." The lesson was: information must be handled as a chain of evidence, not as a single rumor.

In 2026 they said this voice did not fit the broadcast. The market always needs someone willing to speak. And what needs to be said here is this: the story of four beauty brands launching the same product is not a story about business ethics. It is a story about contracts. More specifically, it is a story about what was not written into the contracts.

When a brand pays to differentiate and then watches that differentiation dissolve on the shelf, it has lost control over part of its assets. That asset is not the formula. It is the packaging — the first and sometimes only thing consumers see.

If this story teaches anything to market players, it is this: never let a strategic chokepoint sit outside your control without a clause drafted tightly enough to protect you. In the transfer market, people call that a release clause and a signing bonus. In consumer goods, people call it a supplier exclusivity clause. Both are the same thing: the right to self-determination.

I walk into a meeting room with a phone and walk out with an entire market. In this market, the buyer is the one holding the key. And the question I leave behind is not "who copied whom." The question is: when four brands stand before one supplier, who will be the one to sign a clause tight enough that next time they do not have to say they were lied to?